H2B.W2, a spermatocyte-specific histone variant, disrupts nucleosome stability, and reduces chromatin compaction
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von April T T Nguyen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, NT, HKSAR, China. Hauptthemen laut MEDLINE: Nucleosomes, Histones, Spermatocytes, Chromatin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hong Kong Innovation & Technology Commission Innovation and Technology Fund, National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Commission.
Abstract (Originalsprache)
Spermatogenesis is a highly regulated process that requires precise chromatin remodeling, which includes the incorporation of testis-specific histone variants. While several of these variants have been characterized, the role of H2B.W2, a member of the H2BW family, remains largely unclear. Here, we showed that H2B.W2 expression occurs mainly in spermatocytes, slightly later than its paralog H2B.W1. Cryo-electron microscopy analysis of H2B.W2-containing nucleosomes reveals a more relaxed conformation compared to canonical nucleosomes caused by weakened interactions between the outer DNA turn and the histone core. We pinpointed the N-terminal tail and α2 helix of H2B.W2 as critical regions for nucleosome destabilization. Furthermore, we identify G73 within the L1 loop as a key residue involved in disrupting higher-order chromatin structure. Our findings suggest that H2B.W2-mediated nucleosome and chromatin destabilization may play a role in regulating gene expression during spermatogenesis, with potential implications for sperm development and function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, NT, HKSAR, China.
- Present address:Centre for Translational Stem Cell Biology, Hong Kong Science and Technology Park, Shatin, New Territories, Hong Kong, HKSAR, China.
- Present address:Institute of Biophysics, Chinese Academy of Science, Chaoyang, Beijing 100101, China.
- School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong, HKSAR, China.
- Biological Cryo-EM Center, The Hong Kong University of Science and Technology, Clear Water Bay, NT, HKSAR, China.
- Shenzhen Peking University, The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangzhou 518055, China.
ORCID-Profile: April T T Nguyen, Dongbo Ding, Matthew Y H Pang, Yuanliang Zhai, Toyotaka Ishibashi
Förderung
- Hong Kong Innovation & Technology Commission Innovation and Technology Fund
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Commission
- Research Grants Council of the Hong Kong SAR
Zitieren
APA
Nguyen, A. T. T., Ding, D., Bai, X., Pang, M. Y. H., Deng, M., Liu, Y., Jin, T., Xu, Z., Zhang, Y., Zhai, Y., Yan, Y., & Ishibashi, T. (2025). H2B.W2, a spermatocyte-specific histone variant, disrupts nucleosome stability, and reduces chromatin compaction. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf825
Vancouver
Nguyen ATT, Ding D, Bai X, Pang MYH, Deng M, Liu Y, et al. H2B.W2, a spermatocyte-specific histone variant, disrupts nucleosome stability, and reduces chromatin compaction. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf825
BibTeX
@article{Nguyen2025,
author = {Nguyen, April T T and Ding, Dongbo and Bai, Xingpeng and Pang, Matthew Y H and Deng, Mingxi and Liu, Yue and Jin, Tingyu and Xu, Zhichun and Zhang, Yingyi and Zhai, Yuanliang and Yan, Yan and Ishibashi, Toyotaka},
title = {H2B.W2, a spermatocyte-specific histone variant, disrupts nucleosome stability, and reduces chromatin compaction},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf825}
}
EUVIMED